← FDA Drug Approvals (Drugs@FDA)

WELTRUZA

NDA · New Drug Application · Sponsor: TEVA NEUROSCIENCE INC · Approved 2026-10-08

Drug application

FDA Application #

NDA219007

Application type

New Drug Application

Brand name

WELTRUZA

Generic name

Olanzapine

Active ingredients

OLANZAPINE

Dosage form

SUSPENSION, EXTENDED RELEASE

Route

INJECTABLE

Marketing status

Prescription

Sponsor

TEVA NEUROSCIENCE INC

First approval

2026-10-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown